SCOPUS 정보 검색 플랫폼

Clinical Pharmacology and Therapeutics

Volumn 72, Issue 3, 2002, Pages 229-237

Equivalence approaches

(3) Williams, Roger L a,b Chen, Mei Ling a,b Hauck, Walter W a,b

a CENTER FOR DRUG EVALUATION AND RESEARCH (United States)

b THOMAS JEFFERSON UNIVERSITY (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WARFARIN;

BIOAVAILABILITY; BIOEQUIVALENCE; CLINICAL MEDICINE; CONFIDENCE INTERVAL; DRUG EFFICACY; DRUG SAFETY; HUMAN; NOTE; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

CLINICAL TRIALS; CONFIDENCE INTERVALS; ENDPOINT DETERMINATION; HUMANS; TERMINOLOGY; THERAPEUTIC EQUIVALENCY;

EID: 0036739716 PISSN: 00099236 EISSN: None Source Type: Journal
DOI: 10.1067/mcp.2002.126705 Document Type: Note

Times cited : (56)

References (38)

1
- 0024988106
- Consideration of individual bioequivalence
- (1990) J Pharmacokinet Biopharm , vol.18 , pp. 259-273
- Anderson, S.¹ Hauck, W.W.²

2
- 0026481178
- Bioequivalence revisited
- (1992) Stats Med , vol.11 , pp. 1777-1788
- Sheiner, L.B.¹

3
- 0003922013
- Rockville (MD): Office of Training and Communications, Division of Communications Management, Drug Information Branch HFD-210, Jan
- (2001) Guidance: statistical approaches to establishing bioequivalence

4
- 0001914941
- A unified view of individual, population and average bioequivalence
- Blume HH, Midha KK, editors. Stuttgart (Germany): Medpharm Scientific Publications
- (1995) Bio-International 2: bioavailability, bioequivalence and pharmacokinetic studies , pp. 91-105
- Schall, R.¹

5
- 0026597801
- Types of bioequivalence and related statistical considerations
- (1992) Int J Clin Pharmacol Ther , vol.30 , pp. 181-187
- Hauck, W.W.¹ Anderson, S.²

6
- 0024947084
- The subject-by-formulation interaction as a criterion of interchangeability of drugs
- (1989) Biometrics , vol.45 , pp. 1249-1254
- Ekbohm, G.¹ Melander, H.²

7
- 0030949859
- Individual bioequivalence - A regulatory update
- with discussion
- (1997) J Biopharm Stat , vol.7 , pp. 5-111
- Chen, M.L.¹

8
- 0034735563
- An individual bioequivalence criterion: Regulatory considerations
- (2000) Stat Med , vol.19 , pp. 2821-2842
- Chen, M.L.¹ Patnaik, R.² Hauck, W.W.³ Schuirmann, D.J.⁴ Hyslop, T.⁵ Williams, R.L.⁶

9
- 0029965765
- The assessment of individual and population bioequivalence
- (1996) J Biopharm Stat , vol.6 , pp. 1-14
- Chinchilli, V.M.¹

10
- 0030464885
- Mean difference vs variability reduction: Tradeoffs in aggregate measures for individual bioequivalence
- (1996) Int J Clin Pharmacol Ther , vol.34 , pp. 535-541
- Hauck, W.W.¹ Chen, M.L.² Hyslop, T.³ Patnaik, R.N.⁴ Schuirmann, D.J.⁵ Williams, R.L.⁶

11
- 0034735561
- A small-sample confidence interval approach to assess individual bioequivalence
- (2000) Stat Med , vol.19 , pp. 2885-2897
- Hyslop, T.¹ Hsuan, F.² Holder, D.J.³

12
- 0030771117
- Individual bioequivalence: New concepts in the statistical assessment of bioequivalence metrics
- (1997) Clin Pharmacokinet , vol.33 , pp. 1-6
- Patnaik, R.N.¹ Lesko, L.J.² Chen, M.L.³ Williams, R.L.⁴

13
- 0030011261
- Towards a practical strategy for assessing individual bioequivalence
- (1996) J Pharmacokinet Biopharm , vol.24 , pp. 133-149
- Schall, R.¹ Williams, R.L.²

14
- 0010461560
- (1998) International Conference on Harmonization. E9 statistical principles for clinical trials

15
- 0028291201
- Extention to the use of tolerance intervals for the assessment of individual bioequivalence
- (1994) J Biopharm Stat , vol.4 , pp. 39-52
- Esinhart, J.D.¹ Chinchilli, V.M.²

16
- 0029083127
- Assessment of individual and population bioequivalence using the probability that bioavailabilities are similar
- (1995) Biometrics , vol.51 , pp. 615-626
- Schall, R.¹

17
- 0001474373
- Moment-based criteria for determining bioequivalence
- (1993) Biometrika , vol.80 , pp. 835-846
- Holder, D.J.¹ Hsuan, F.²

18
- 25944477220
- Preface - Statistical criteria for bioequivalence
- Rockville (MD): Office of Information Technology, Center for Drug Evaluation and Research
- (2002) Approved drug products with therapeutic equivalence evaluations. 22nd ed.

19
- 0010421047
- (2001) International Conference on Harmonization. E10 Choice of control group in clinical trials

20
- 0023615056
- A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability
- (1987) J Pharmacokinet Biopharm , vol.15 , pp. 657-680
- Schuirmann, D.J.¹

21
- 0018411703
- Statistical aspects of comparative bioavailability trials
- (1979) Biometrics , vol.35 , pp. 273-280
- Westlake, W.J.¹

22
- 0001305791
- Response to Kirkwood, TBL: Bioequivalence testing - A need to rethink
- (1981) Biometrics , vol.37 , pp. 589-594
- Westlake, W.J.¹

23
- 0000470568
- Bioavailability and bioequivalence of pharmaceutical formulations
- Peace KE, editor. New York: Marcel Dekker
- (1988) Biopharmaceutical statistics for drug development , pp. 329-352
- Westlake, W.J.¹

24
- 0021702968
- An exact confidence interval from untransformed data for the ratio of two formulation means
- (1984) J Pharmacokinet Biopharm , vol.12 , pp. 649-655
- Locke, C.S.¹

25
- 84923818429
- Better bootstrap confidence intervals
- with discussion
- (1987) J Am Stat Assoc , vol.82 , pp. 171-200
- Efron, B.¹

26
- 0000521797
- Confidence intervals on nonnegative linear combinations of variances
- (1980) J Am Stat Assoc , vol.75 , pp. 869-873
- Graybill, F.¹ Wang, C.M.²

27
- 0000722255
- Approximate confidence limits on the mean of X+Y where X and Y are two tabled independent random variables
- (1974) J Am Stat Assoc , vol.69 , pp. 789-794
- Howe, W.G.¹

28
- 0000224613
- Confidence intervals associated with tests for bioequivalence
- (1994) Biometrika , vol.81 , pp. 103-114
- Hsu, J.C.¹ Hwang, J.T.G.² Liu, H.K.³ Ruberg, S.J.⁴

29
- 0031396991
- A parametric confidence interval for a moment-based scaled criterion for individual bioequivalence
- (1998) J Pharm Biopharm , vol.25 , pp. 595-614
- Kimanani, E.K.¹ Potvin, D.²

30
- 0002068388
- Confidence intervals on linear combinations of variance components that are unrestricted in sign
- (1990) J Stat Comp Sim , vol.35 , pp. 135-143
- Ting, N.¹ Burdick, R.K.² Graybill, F.A.³ Jeyaratnam, S.⁴ Lu, T.F.C.⁵

31
- 0010503611
- Treatment of bioequivalence data: Log transformation
- Toronto, Ontario, Canada; October 1-4, 1989. Toronto: The Conference
- (1989) Proceedings of Bio-International '89 - issues in the evaluation of bioavailability data , pp. 159-161
- Schuirmann, D.J.¹

32
- 0033004225
- Some issues in the design and analysis of equivalence trials
- (1999) Drug Info J , vol.33 , pp. 109-118
- Hauck, W.W.¹ Anderson, S.²

33
- 0034655549
- Generalized treatment effects for clinical trials
- (2000) Stat Med , vol.19 , pp. 887-899
- Hauck, W.W.¹ Hyslop, T.² Anderson, S.³

34
- 0010463370
- (1998) International Conference on Harmonization. E5 ethnic factors in the acceptability of foreign clinical data

35
- 0033725193
- Pharmacokinetic analysis of bioequivalence trials: Implication for sex-related issues in clinical pharmacology and biopharmaceutics
- (2000) Clin Pharmacol Ther , vol.68 , pp. 510-521
- Chen, M.L.¹ Lee, S.C.² Ng, M.J.³ Schuirmann, D.J.⁴ Lesko, L.J.⁵ Williams, R.L.⁶

36
- 0003444414
- Rockville (MD): Dept. of Health and Human Services (US), Food and Drug Administration, May
- (1999) Managing the risks from medical product use. Report to the FDA Commissioner

37
- 4244075794
- Rockville (MD): Food and Drug Administration, Center for Drug Evaluation and Research, Advisory Committee for Pharmaceutical Science, Sept
- (1999) Drug-drug interaction: introduction , pp. 24
- Williams, R.L.¹

38
- 25944446689
- Rockville (MD): Food and Drug Administration, Center for Drug Evaluation and Research, Advisory Committee for Pharmaceutical Science, Sept
- (1999) Replicate and non-replicate data sets , pp. 23
- Williams, R.L.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.